Sartel-Beta 25 Tablet (Telmisartan 40mg / Metoprolol Succinate 25mg)

Overview

Sartel-Beta 25 ER Tablet is used for High blood pressure, Heart attack, Heart failure, Kidney failure in patients with diabetes, Hypertension, Angina pectoris and other conditions. Sartel-Beta 25 ER Tablet may also be used for purposes not listed in this medication guide.

Sartel-Beta 25 ER Tablet contains Metoprolol Succinate and Telmisartan as active ingredients.
Sartel-Beta 25 ER Tablet works by blocking the action of a substance responsible for narrowing the blood vessels; suppressing the beta 2-adrenoreceptors activity; possessing the beta-blocking activity;
Detailed information related to Sartel-Beta 25 ER Tablet’s uses, composition, dosage, side effects and reviews is listed below.

Uses

Sartel-Beta 25 ER Tablet is used for the treatment, control, prevention, & improvement of the following diseases, conditions and symptoms:
High blood pressure
Heart attack
Heart failure
Kidney failure in patients with diabetes
Hypertension
Angina pectoris

Side-effects

The following is a list of possible side-effects that may occur from all constituting ingredients of Sartel-Beta 25 ER Tablet. This is not a comprehensive list. These side-effects are possible, but do not always occur. Some of the side-effects may be rare but serious. Consult your doctor if you observe any of the following side-effects, especially if they do not go away.
Cough
Hypersensitivity
Low blood pressure
Rapid swelling of face or lips
Vomiting
Bloating
Itching
Muscle cramps
Pain
Tiredness
Dizziness
Shortness of breath
Bradycardia
Palpitations
Congestive heart failure
Peripheral edema
Wheezing
Nausea
Dry mouth
Gastric pain
Constipation
Flatulence
Digestive tract disorders
Heartburn
Diarrhea
Rash
Sartel-Beta 25 ER Tablet may also cause side-effects not listed here.
If you notice other side-effects not listed above, contact your doctor for medical advice. You may also report side-effects to your local food and drug administration authority.

Related Product

Precautions

Before using Sartel-Beta 25 ER Tablet, inform your doctor about your current list of medications, over the counter products (e.g. vitamins, herbal supplements, etc.), allergies, pre-existing diseases, and current health conditions (e.g. pregnancy, upcoming surgery, etc.). Some health conditions may make you more susceptible to the side-effects of the drug. Take as directed by your doctor or follow the direction printed on the product insert. Dosage is based on your condition. Tell your doctor if your condition persists or worsens. Important counseling points are listed below.
Get your blood pressure, potassium and kidney function checked 1 week after starting this medicine
diabetic patients
patients with ischemic heart disease
patients with peripheral vascular disease

Interactions with Sartel-Beta 25 ER Tablet

If you use other drugs or over the counter products at the same time, the effects of Sartel-Beta 25 ER Tablet may change. This may increase your risk for side-effects or cause your drug not to work properly. Tell your doctor about all the drugs, vitamins, and herbal supplements you are using, so that you doctor can help you prevent or manage drug interactions. Sartel-Beta 25 ER Tablet may interact with the following drugs and products:
Acetylsalicylic acid
Amifostine
Amiloride
Clonidine
Diclofenac
Digoxin
Fenoprofen
Fluoxetine
Flurbiprofen
Ketoprofen

When not to use Sartel-Beta 25 ER Tablet

Hypersensitivity to Sartel-Beta 25 ER Tablet is a contraindication. In addition, Sartel-Beta 25 ER Tablet should not be used if you have the following conditions:
Breastfeeding
Hepatic impairment
Hypersensitivity
Obstructive biliary disorders
Pregnant
cardiogenic shock
decompensated cardiac failure
heart block greater than first degree
hypersensitivity
severe bradycardia

Composition and Active Ingredients

Sartel-Beta 25 ER Tablet is composed of the following active ingredients (salts)
Telmisartan – 40mg
Metoprolol Succinate – 25mg